Skip to main content
OpenTrials
Completed

NCT Number: NCT02961439

Validation of Epworth Richmond's Echocardiography Education Focused Year

The use of echocardiography in intensive care is a developing field. In expert hands echocardiography has proven its utility in diagnosing cardiac pathology, differentiating shock states and in haemodynamic monitoring. However, whether the results obtained by experts can be generalized to trainees or specialists with limited training remains unclear. Further, concerns around training time and cost for intensive care staff have been a factor in limiting the uptake of echocardiography in intensive care.

The investigators aim to assess the diagnostic accuracy of Australian ICU doctors in training after completion of the current minimum training. After completing a structured teaching program and 30 mentored training scans trainees will be assessed on their accuracy with echocardiography. In the research phase trainees will complete a further 40 scans with each one matched with an expect scan. The results from the expert and trainee scans will be compared to determine the trainee's accuracy.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Registrar Inclusion:

  • At least 12 month appointment in Epworth Richmond ICU
  • Completion of theoretical component of Epworth Richmond ICU echocardiography program
  • Completion of 30 echocardiography scans

Registrar Exclusion:

  • Previous experience in echocardiography prior to commencing at Epworth Richmond.

Patient Inclusion

  • Patient in ICU or CCU
  • 18 years or older
  • Not likely to be discharged before completion of the scan

Patient Exclusion

  • Likely to be discharged within next two hours
  • Atrial fibrillation
  • Presence of subcostal or intercostal drains or pneumothorax
  • Unable to be consented
  • Treating intensivist deems inclusion in study not suitable.

Treatment and study plan

Epworth Richmond's Echocardiography Focused Year

Behavioral

a year long echo teaching program

Primary outcomes

  1. Agreement between registrar and expert assessment of Left ventricular (LV) function

    Time frame: Four months

Secondary outcomes

  1. Comparison of expert and registrar quantitative measures of Left vwentricular Internal Diameter in Diastole (LVIDd)

    Time frame: Four months

  2. Comparison of expert and registrar quantitative measures of Left Ventricular Outflow Tract (LVOT) diameter

    Time frame: Four months

  3. Comparison of expert and registrar quantitative measures of Left Ventricular Outflow Tract Velocity Time Integral (LVOT VTI)

    Time frame: Four months

  4. Comparison of expert and registrar quantitative measures of TR V max

    Time frame: Four months

  5. Comparison of expert and registrar quantitative measures of Tricuspid annular Plane Systolic Excursion (TAPSE)

    Time frame: Four months

  6. Comparison of expert and registrar quantitative measures of IVC diameter

    Time frame: Four months

  7. Comparison of expert and registrar qualitative assessment of pericardial fluid

    Time frame: Four months

  8. Comparison of expert and registrar qualitative assessment of Left Ventricle : Right Ventricle size ratio

    Time frame: Four months

Sponsors and collaborators

Lead sponsor

Epworth Healthcare

Other

Collaborators

  • University of Melbourne

Registry information

Acronym: VEREEFY

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Nov 11, 2016
Registry last updated
Aug 10, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.